2m 2m 2m 2m 2m 2m 2m
LYELL IMMUNPHRM (LYEL)
NASDAQ
$16.86+$0.11 (+0.66%)
Price as of Nov 11, 2026 4:10 PM EST- $411.8MMarket Cap
- -2.90%1-Year Change
- BiotechnologyIndustry
LYELL IMMUNPHRM (LYEL)
$16.86+$0.11 (+0.66%)
LYEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.75 | ||
Change | +$1.33 (+8.63%) | ||
Open | $15.17 | ||
High | $17.01 | ||
Low | $14.92 | ||
Previous Close | $15.42 | ||
Volume | 228,298 | ||
30-Day Average Volume | 243,573 | ||
1-Week Change | 55.52% | ||
1-Month Change | 92.31% | ||
1-Year Change | -2.90% | ||
3-Year Change | -49.40% | ||
5-Year Change | -93.05% | ||
Fundamentals | |||
Shares Outstanding | 24.6M | ||
Total Assets | $273.9M | ||
Market Cap | $411.8M | ||
Enterprise Value | $319.8M | ||
Period: QTR TTM FY | |||
Revenue | $3,000.00 | ||
Net Income | -$45.5M | ||
Free Cash Flow | -$34.6M | ||
EBIT | -$45.5M | ||
EBITDA | -$43.5M | ||
Net Working Capital | $139.9M | ||
EPS | -$1.86 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 106,585 | ||
P/B | 2 | ||
P/E | -9 | ||
PEG | -3 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/02/2025 | ||
Earnings & Revenue